Form 4 for ELAN Elanco Animal Health Inc
Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-12 · accession 0001415889-24-021121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-08-13 | 2024-08-12 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | P - Purchase | $13.01 | +100.0K | 145.0K | +222% | +$1.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | P | A | 100,000 | $13.01 | 145,000 | I By Revocable Trust | — | — | (F1) Reflects the weighted average price of 100,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 12, 2024 with purchase prices ranging from $12.9985 to $13.0662 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |